Could a diabetes drug curb alcohol cravings after bariatric surgery?
NCT ID NCT07223983
First seen Nov 03, 2025 · Last updated May 25, 2026 · Updated 31 times
Summary
This early study tests whether semaglutide, a medication used for diabetes and weight loss, can help people who have had bariatric surgery and now struggle with alcohol use disorder. Ten adults will take semaglutide for three months and be followed for three more months to see if it reduces drinking and helps maintain weight loss. The goal is to see if this approach is feasible and worth studying in larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yale School of Medicine
RECRUITINGNew Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.